AC Immune (ACIU) Cash from Investing Activities (2015 - 2025)

AC Immune (ACIU) has 11 years of Cash from Investing Activities data on file, last reported at $20.0 million in Q4 2025.

• On a quarterly basis, Cash from Investing Activities rose 558.45% year-over-year to $20.0 million in Q4 2025; TTM through Dec 2025 was $78.0 million, a 166.34% increase from a year earlier, with the FY2025 full-year figure at $76.6 million, up 163.77% from the prior year.
• Cash from Investing Activities for Q4 2025 stood at $20.0 million, down from $25.8 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for ACIU reached as high as $46.3 million in Q1 2023 and fell as low as -$83.8 million in Q2 2024.
• Historically, Cash from Investing Activities has averaged -$69004.6 across 5 years, with a median of -$561917.7 in 2021.
• Across the five-year window, Cash from Investing Activities jumped 8013.88% in 2023 and sank 1362.29% in 2024, its largest moves.
• Year by year, Cash from Investing Activities stood at -$23.6 million in 2021, then soared by 121.85% to $5.1 million in 2022, then soared by 409.85% to $26.2 million in 2023, then tumbled by 116.64% to -$4.4 million in 2024, then soared by 558.45% to $20.0 million in 2025.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $20.0 million in Q4 2025, $25.8 million in Q3 2025, and $28.8 million in Q2 2025.